Company also provides update on strategy for addressing SARS-CoV-2 variants of concern CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 24, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces that it has completed manufacturing
investors.modernatx.com